Streetbeat News

Stock Prices

MSAI

MultiSensor AI has filed a Form S1 for a common stock offering of up to $10 million.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:40 am

GB

Global Blue reports a significant recovery in May 2024, with a 172% increase compared to 153% in April and 140% in Q1. This growth is driven by strong momentum across various nationalities.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:40 am

SSNLF

Samsung Electronics Co. faced its first-ever strike from its largest union over a pay dispute, involving around 28,400 workers. The strike, described as a 'soft start,' could escalate if management remains unresponsive. The core issue is the distribution of bonuses, particularly in the semiconductor division. Despite the strike, Samsung reports no impact on production or management.

Portfolio Pulse from Shivani Kumaresan

June 07, 2024 | 10:37 am

NVDA

Nvidia Corp. (NASDAQ:NVDA) shares retreated after breaching the $3 trillion market cap. Options strategist Matt Amberson discussed the high volatility and pricing of Nvidia options ahead of the company's 10-for-1 stock split. The split aims to make the stock more affordable for retail traders. Nvidia also announced a 150% increase in its quarterly dividend. Despite its dominant position in AI, some experts question its valuation.

Portfolio Pulse from Shanthi Rexaline

June 07, 2024 | 10:35 am

GHM

Graham (NYSE:GHM) reported Q4 2024 adjusted EPS of $0.15, significantly beating the analyst estimate of $0.04. The company also reported sales of $49.070 million, surpassing the $44.500 million estimate and marking a 14.04% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:32 am

IMOS

ChipMOS reported May revenues of $62.3 million, marking a 10.4% year-over-year increase. The company attributes this growth to improved customer inventory stabilization and broader market growth.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:31 am

BMEA

Biomea Fusion, Inc. (NASDAQ:BMEA) saw its stock drop by 60.3% pre-market after the FDA imposed a full clinical hold on its Phase I/II trials for BMF-219, a diabetes treatment, due to concerns over potential drug-induced hepatotoxicity. Despite the hold, the company will continue to gather safety and efficacy data.

Portfolio Pulse from Benzinga Neuro

June 07, 2024 | 10:20 am

CYD

China Yuchai announced that it may repurchase its ordinary shares up to $40 million in dollar amount or 4 million in number, whichever occurs earlier.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:09 am

GME

GameStop announced that it will not be holding a conference call today.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:09 am

GME

GameStop (NYSE:GME) reported Q1 adjusted EPS of $(0.12), missing the $(0.09) estimate, and sales of $881.80M, missing the $1.05B estimate. This represents a 14.29% improvement in EPS but a 28.71% decline in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 10:08 am